Printer Friendly

IVAX CORPORATION AND TRINITY CAPITAL ENTERPRISE CORP. AGREE TO TERMINATE PROPOSED TRANSACTION

 MIAMI, Nov. 19 ~PRNewswire~ -- IVAX Corporation (AMEX: IVX) announced that it mutually agreed with Trinity Capital Enterprise Corp. (NASDAQ: TICO) to terminate the proposed transaction involving the business combination among Trinity and IVAX' wholly owned subsidiaries, Diamedix Corporation and GDU Trading Company, Ltd.
 IVAX Corporation is a holding company with subsidiaries involved in specialty chemicals, pharmaceuticals and medical diagnostics. IVAX' principal subsidiaries include Baker Norton Pharmaceuticals, Inc., a developer and marketer of unique brand name pharmaceuticals; Norton Healthcare Limited, a leading manufacturer and marketer of off-patent pharmaceuticals in the United Kingdom, Ireland and other countries; LuChem Pharmaceuticals, Inc., a manufacturer of off- patent pharmaceuticals in the United States; Goldline Laboratories, Inc., a national marketer of off-patent prescription and over-the- counter pharmaceuticals in the United States; Baker Cummins Dermatologicals, Inc., a dermatological products company; Flori Roberts, Inc., a skin care and cosmetics company; DVM Pharmaceuticals Inc., a veterinary products company; Diamedix Corporation, a medical diagnostics company; Delta Biologicals S.r.l., a marketer of medical diagnostic tests and instruments in Italy; and IVAX Industries, Inc., a chemical specialties business.
 -0- 11~19~92
 ~CONTACT: Richard C. Pfenniger Jr., senior vice president of legal affairs of IVAX Corporation, 305-590-2309~
 (IVX TICO)


CO: IVAX Corporation; Trinity Capital Enterprise Corp. ST: Florida IN: MTC SU:

AW-SS -- FL003 -- 2728 11~19~92 09:34 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 19, 1992
Words:220
Previous Article:20,000 DU PONT/CONOCO/CONSOL WORKERS STAGE SOLIDARITY PROTEST
Next Article:BANKATLANTIC VOLUNTEERS TO ASK MOTORISTS TO SUPPORT HABITAT FOR HUMANITY OF BROWARD THIS SATURDAY, NOV. 21
Topics:


Related Articles
IVAX ENTERS INTO AGREEMENT TO ACQUIRE WILLEN DRUG COMPANY
IVAX ENTERS INTO AGREEMENT TO ACQUIRE THE SOLOPAK DIVISION OF SMITH & NEPHEW, INC.
IVAX DETERMINES NOT TO PROCEED WITH ACQUISITION OF THE SOLOPAK DIVISION OF SMITH & NEPHEW, INC.
ZENITH LABORATORIES, INC. TO MERGE WITH IVAX CORPORATION; WILL CREATE WORLD'S LARGEST GENERIC PHARMACEUTICAL COMPANY
DR. PHILIP FROST ENTITY TO ACQUIRE 5.3% POSITION IN MEDICIS
IVAX CORPORATION AND ZENITH LABORATORIES, INC. ANNOUNCE COMPLIANCE WITH FTC REQUEST
IVAX AND HAFSLUND NYCOMED REPLACE MERGER AGREEMENT WITH STRATEGIC ALLIANCE IN PHARMACEUTICAL SECTOR
Merger Agreement Between IVAX and Bergen Terminated
IVAX Corporation To Sell Soft-Gel Business To Goldstar Pharmaceuticals
IVAX Corporation's Proposed Transaction To Sell Soft-Gel Business Terminated

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters